BlackRock Health Sciences Term Trust (NYSE:BMEZ) Stock Short Interest Rises 178.9%

BlackRock Health Sciences Term Trust (NYSE:BMEZ) was the target of a large increase in short interest in the month of September. As of September 15th, there was short interest totaling 83,940 shares, an increase of 178.9% from the August 31st total of 30,094 shares. Based on an average daily volume of 145,862 shares, the days-to-cover ratio is currently 0.6 days.

Institutional Investors Weigh In On BlackRock Health Sciences Term Trust

Several institutional investors have recently modified their holdings of the company. SouthState Bank Corp acquired a new position in BlackRock Health Sciences Term Trust during the first quarter worth $29,000. PNC Financial Services Group Inc. acquired a new position in shares of BlackRock Health Sciences Term Trust during the 1st quarter worth $35,000. Integrated Wealth Concepts LLC acquired a new position in shares of BlackRock Health Sciences Term Trust during the 2nd quarter worth $46,000. Fifth Third Bancorp purchased a new stake in shares of BlackRock Health Sciences Term Trust in the 1st quarter worth about $142,000. Finally, Prospera Financial Services Inc purchased a new stake in shares of BlackRock Health Sciences Term Trust in the 4th quarter worth about $179,000.

BlackRock Health Sciences Term Trust Trading Up 0.2%

Shares of BMEZ opened at $16.84 on Tuesday. BlackRock Health Sciences Term Trust has a 52-week low of $13.70 and a 52-week high of $17.25. The company has a 50-day simple moving average of $16.33 and a 200-day simple moving average of $15.14.

BlackRock Health Sciences Term Trust Announces Dividend

The business also recently announced a monthly dividend, which will be paid on Tuesday, December 22nd. Shareholders of record on Friday, December 11th will be issued a $0.11 dividend. The ex-dividend date of this dividend is Friday, December 11th. This represents a $1.32 dividend on an annualized basis and a yield of 7.8%.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Term Trust (NYSE:BMEZ) is a publicly traded closed-end investment fund managed by BlackRock Advisors, LLC. The fund seeks to provide total returns through a combination of current income and long-term capital appreciation by investing primarily in companies involved in the health sciences sector.

BMEZ’s investment universe includes businesses in areas such as biotechnology, pharmaceuticals, medical devices, health-care services, and life-sciences tools and equipment.